Detalhe da pesquisa
1.
Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy.
Br J Cancer
; 129(11): 1766-1772, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813958
2.
Sodium Bicarbonate for Metabolic Acidosis in the ICU: Results of a Pilot Randomized Double-Blind Clinical Trial.
Crit Care Med
; 51(11): e221-e233, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294139
3.
The nature and impact of patient and public involvement in cancer prevention, screening and early detection research: A systematic review.
Prev Med
; 167: 107412, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592674
4.
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.
Future Oncol
; 19(34): 2277-2289, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746835
5.
Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.
Br J Cancer
; 126(5): 693-705, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663949
6.
Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary.
Br J Cancer
; 127(3): 531-540, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484217
7.
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer.
Br J Cancer
; 127(8): 1473-1478, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869145
8.
Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes.
Oncologist
; 27(2): 97-103, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641203
9.
Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy.
Acta Oncol
; 61(5): 583-590, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392758
10.
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
Oncologist
; 26(4): e669-e678, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210382
11.
Liver Embolisation for Patients with Neuroendocrine Neoplasms: Systematic Review.
Neuroendocrinology
; 111(4): 354-369, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32172229
12.
Molecular targeted therapies: Ready for "prime time" in biliary tract cancer.
J Hepatol
; 73(1): 170-185, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171892
13.
Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer.
J Hepatol
; 73(5): 1109-1117, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446715
14.
Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectives.
Curr Opin Oncol
; 32(4): 364-369, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541326
15.
Impact on prognosis of early weight loss during palliative chemotherapy in patients diagnosed with advanced pancreatic cancer.
Pancreatology
; 20(8): 1682-1688, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046391
16.
The assessment of pancreatic exocrine function in patients with inoperable pancreatic cancer: In need of a new gold-standard.
Pancreatology
; 20(4): 668-675, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32284260
17.
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine Neoplasms.
Neuroendocrinology
; 110(7-8): 688-696, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31639796
18.
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121).
Future Oncol
; 16(16): 1069-1081, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32374623
19.
18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis.
J Hepatol
; 71(1): 115-129, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30797051
20.
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas.
Neuroendocrinology
; 109(2): 100-112, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30703770